Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

ritonavir-encapsulated folic acid-conjugated poloxamer 407 nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

HEPES buffer

Type Complex Compound
Formula
Role core
2

folic acid-conjugated poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)

folic acid-conjugated poloxamer 407 FA-P407
Type Polymer
Formula
Role layer
3

(5S,8S,10S,11S)-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid 5-thiazolyl-methyl ester

ritonavir RTV
Type Single Compound
Formula C37H48N6O5S2
Role loaded material

Properties

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • HEPES buffer
  • folic acid-conjugated poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
  • (5S,8S,10S,11S)-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid 5-thiazolyl-methyl ester
  1. 1ky6Tl9t
Product

ritonavir-encapsulated folic acid-conjugated poloxamer 407 nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial